Pharmacokinetic Drug Interactions of Apatinib With Rifampin and Itraconazole-Reference-Cited by-同舟云学术

Pharmacokinetic Drug Interactions of Apatinib With Rifampin and Itraconazole

Published:2017-10-02 Issue:3 Volume:58 Page:347-356
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Liu Xiaoyun¹²,Zhang Yifan¹,Chen Qian³,Zhan Yan¹,Wang Quanren⁴,Hu Chaoying³,Yu Chen³,Guo Zitao¹,Chen Xiaoyan¹²,Zhong Dafang¹²

Affiliation:

1. Shanghai Institute of Materia MedicaChinese Academy of Sciences Shanghai China

2. University of Chinese Academy of Sciences Beijing China

3. Shanghai Xuhui Central Hospital Shanghai China

4. Jiangsu Hengrui Medicine Co. Ltd. Lianyungang China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1016

Reference26 articles.

1. Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer

2. Successful treatment with apatinib for refractory recurrent malignant gliomas: a case series;Zhang HH;Onco Targets Ther,2017

3. Apatinib treatment combined with chemotherapy for advanced epithelial ovarian cancer: a case report;Deng LH;Onco Targets Ther,2017

4. Public summary of opinion on orphan designation N‐(4‐(1‐cyanocyclopentyl)phenyl)‐2‐(4‐pyridinylmethyl)amino‐3‐pyridinecarboxamide methanesulfonate for the treatment of gastric cancer. European Medicines Agency.http://www.ema.europa.eu/docs/en_GB/document_library/Orphan_designation/2017/03/WC500224877.pdf. Accessed June 2 2017.

5. Population Pharmacokinetic and Covariate Analysis of Apatinib, an Oral Tyrosine Kinase Inhibitor, in Healthy Volunteers and Patients with Solid Tumors

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibitory effects of the main metabolites of Apatinib on CYP450 isozymes in human and rat liver microsomes;Toxicology in Vitro;2024-03

2. A Drug–Drug Interaction Study to Evaluate the Impact of Simvastatin and Itraconazole on Erlotinib Pharmacokinetics in Rats by UPLC-MS/MS;Drug Design, Development and Therapy;2023-10

3. Effects of the CYP3A inhibitors, voriconazole, itraconazole, and fluconazole on the pharmacokinetics of osimertinib in rats;PeerJ;2023-08-10

4. Pharmacokinetics, safety, tolerability, and feasibility of apatinib in combination with gefitinib in stage IIIB-IV EGFR-mutated non-squamous NSCLC: a drug-drug interaction study;Cancer Chemotherapy and Pharmacology;2023-07-31

5. Itraconazole interferes in the pharmacokinetics of fuzuloparib in healthy volunteers;Cancer Chemotherapy and Pharmacology;2023-05-11